Skip to main content

Meet Julian Marschalek, Winner of the NeuEve Award for Best Contribution in Vulvo-Vaginitis Research!


From left to right:
Prof. Dr. Ljubomir Petricevic of Austria, Medical University of Vienna,
Julian Marschalek, Medical University of Vienna,
Prof. Dr. Gilbert Donders of Belgium, President of ISIDOG

Congratulations to Julian Marschalek, for his important contribution to vulvo-vaginitis research!

Julian was awarded a travel scholarship from NeuEve for his journal article published in Breast Care.

NeuEve is very proud and we feel blessed to be able to support young scientists, especially in the extremely important field of woman's health!

He wrote the article: Influence of Orally Administered Probiotic Lactobacillus Strains on Vaginal Microbiota in Women with Breast Cancer during Chemotherapy: A Randomized Placebo-Controlled Double-Blinded Pilot Study

Here's the abstract:

Background: Due to chemotherapy and estrogen deprivation therapy, genitourinary syndrome of menopause is a common condition in breast cancer patients. We aimed to determine the effect of an orally administered Lactobacillus preparation on the vaginal microbiota in breast cancer patients.

Methods: Postmenopausal breast cancer patients receiving chemotherapy, with vaginal atrophy and an intermediate vaginal microbiota (Nugent score 4-6), were either randomized to the intervention group receiving probiotic capsules of 4 Lactobacillus species or to the control group receiving placebo twice daily for 2 weeks. Consecutive vaginal swabs were taken at baseline, 1 day after administration of the last capsule (follow-up 1), and after 1 week (follow-up 2) in 22 patients (11 vs. 11).

Results: We observed a positive influence on the vaginal microbiota in 7/11 (63%) women in the intervention group, and 4/11 (36%) women in the control group. There was a shift in Nugent score towards normal microbiota levels in the intervention group (-1.3 at follow-up 1, -0.45 at follow-up 2) and a significant deterioration of the Nugent score in the control group (+0.4 at follow-up 1, +2.5 at follow-up 2).

Conclusion: The orally administered Lactobacillus preparation has the potential to improve the vaginal microbiota in women undergoing chemotherapy for breast cancer.

© 2017 S. Karger GmbH, Freiburg

Comments

Popular posts from this blog

Posterior Fourchette Fissures, Simply Explained

What is the Posterior Fourchette? The Posterior Fourchette is located at bottom of your vaginal entrance. It is a thin tissue fold and should be able to stretch during sexual intercourse. What is a Posterior Fourchette Fissure and what causes it? If you are approaching menopause, you may have had an OB-GYN exam and felt some sharp pain. You doctor may have told you that you have a Posterior Fourchette Fissure. The main cause for most posterior fourchette fissures is atrophic vulvovaginitis. Other causes of posterior fourchette fissures include yeast infections, lichen sclerosis, and eczema. How does Atrophic Vulvovaginitis affect the Posterior Fourchette? When you are a young healthy woman, sexual activity is usually OK. When you are reaching menopause, your hormone levels drop. Lots of women then experience vaginal dryness. First it can feel like sand paper. As atrophy is progressing, the vaginal tissues start to shrink. Finally, the vaginal entrance could become as tiny …

Stephanie Prima with a heartfelt review of NeuEve

Holistic health mentor Stephanie Prima recently wrote about a heartfelt topic: her personal sexual health and how NeuEve has helped. NeuEve is nothing short of brilliant! Here's more: "I’m creating this post to be as open and honest as I possibly can be about a topic that I have never yet heard anyone talk about. Doctors don’t even have a viable solution for this condition. So it’s scary to make myself this vulnerable. But I trust that my words will once again inspire others. My condition reached a point where inserting anything was too painful and my partner didn’t want to inflict any more on me. While I was emotionally willing and wanting, my body simply couldn’t. For some women, these conditions can result in decreased sensations or libido as well. From this understanding, it’s no wonder so many women entering menopause have little sexual desire. They talk about hot flashes and weight gain, but the rest of the symptoms are simply too embarrassing to admit. I actually fe…

Female Libido and Sexual Dysfunction

Hot Flashes Female Sexual Dysfunction Once women enter menopause, they often talk loudly about hot flashes and night sweats. The elephant in the room is loss of libido. Interest or desire for sex declines. Some women are unable to become aroused, while others cannot achieve orgasm. Moreover, vaginal dryness and atrophy, as well as painful sex, can also result in a loss of libido. The incidence of female sexual dysfunction is high, about 40% among normal aging postmenopausal women and close to 100% among breast cancer survivors who have been on an anti-hormonal therapy. Female sexual dysfunction can have a profound impact on quality of life, but it has been largely ignored by the healthcare community. Major reasons may include: traditional social conservatism, gender inequality, and cultural suppression against women’s sexual desire. Because truly effective remedies are not available, even if women openly seek care for sexual dysfunction, they are often given ineffective treatment…